Biblio
Export 1129 results:
Author [ Title
Filters: First Letter Of Last Name is T [Clear All Filters]
“The Mechanisms of Action of Curcumin in Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1003-1016, 2017.
, “Mechanism of Tau Hyperphosphorylation Involving Lysosomal Enzyme Asparagine Endopeptidase in a Mouse Model of Brain Ischemia.”, J Alzheimers Dis, vol. 63, no. 2, pp. 821-833, 2018.
, “Measuring Information Processing Speed in Mild Cognitive Impairment: Clinical Versus Research Dichotomy.”, J Alzheimers Dis, vol. 51, no. 1, pp. 263-75, 2016.
, “Measuring Information Processing Speed in Mild Cognitive Impairment: Clinical Versus Research Dichotomy.”, J Alzheimers Dis, vol. 51, no. 1, pp. 263-75, 2016.
, “Markers of amyloid-β deposition and burden of enlarged perivascular spaces in patients with cognitive impairment and small vessel disease.”, J Alzheimers Dis, vol. 102, no. 4, pp. 981-986, 2024.
, “Markers of amyloid-β deposition and burden of enlarged perivascular spaces in patients with cognitive impairment and small vessel disease.”, J Alzheimers Dis, vol. 102, no. 4, pp. 981-986, 2024.
, “MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”, J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
, “Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.”, J Alzheimers Dis, vol. 60, no. 1, pp. 273-281, 2017.
, “Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 411-424, 2023.
, “Lung Function Impairment and the Risk of Incident Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 82, no. 2, pp. 621-630, 2021.
, “Lower Prevalence of Alzheimer's Disease among Tibetans: Association with Religious and Genetic Factors.”, J Alzheimers Dis, vol. 50, no. 3, pp. 659-67, 2016.
, “Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice.”, J Alzheimers Dis, vol. 86, no. 2, pp. 641-653, 2022.
, “Low Prevalence of Mixed Dementia in a Cohort of 2,000 Elderly Patients in a Memory Clinic Setting.”, J Alzheimers Dis, vol. 50, no. 3, pp. 797-806, 2016.
, “Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.”, J Alzheimers Dis, vol. 57, no. 3, pp. 697-703, 2017.
, “Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 2, pp. 753-762, 2017.
, “Low Accuracy of Brief Cognitive Tests in Tracking Longitudinal Cognitive Decline in an Asian Elderly Cohort.”, J Alzheimers Dis, vol. 62, no. 1, pp. 409-416, 2018.
, “Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1051-1058, 2023.
, “Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults.”, J Alzheimers Dis, vol. 81, no. 3, pp. 1039-1052, 2021.
, “A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1541-1553, 2018.
, “A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1541-1553, 2018.
, “A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1541-1553, 2018.
, “Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 719-29, 2016.
, “Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 719-29, 2016.
, “Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1105-14, 2016.
, “Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.”, J Alzheimers Dis, vol. 61, no. 1, pp. 321-332, 2018.
,